SG11201602232UA - System for gas treatment of a cell implant - Google Patents

System for gas treatment of a cell implant

Info

Publication number
SG11201602232UA
SG11201602232UA SG11201602232UA SG11201602232UA SG11201602232UA SG 11201602232U A SG11201602232U A SG 11201602232UA SG 11201602232U A SG11201602232U A SG 11201602232UA SG 11201602232U A SG11201602232U A SG 11201602232UA SG 11201602232U A SG11201602232U A SG 11201602232UA
Authority
SG
Singapore
Prior art keywords
gas treatment
cell implant
implant
cell
treatment
Prior art date
Application number
SG11201602232UA
Inventor
Linda Tempelman
Simon Stone
Klearchos Papas
Original Assignee
Giner Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giner Inc filed Critical Giner Inc
Publication of SG11201602232UA publication Critical patent/SG11201602232UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/022—Artificial gland structures using bioreactors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M2005/006—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests for gases, e.g. CO2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14204—Pressure infusion, e.g. using pumps with gas-producing electrochemical cell
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0208—Oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/75—General characteristics of the apparatus with filters
    • A61M2205/7536—General characteristics of the apparatus with filters allowing gas passage, but preventing liquid passage, e.g. liquophobic, hydrophobic, water-repellent membranes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
    • Y02E60/30—Hydrogen technology
    • Y02E60/36—Hydrogen production from non-carbon containing sources, e.g. by water electrolysis

Landscapes

  • Health & Medical Sciences (AREA)
  • Transplantation (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
  • Prostheses (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201602232UA 2013-09-24 2014-09-24 System for gas treatment of a cell implant SG11201602232UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361881654P 2013-09-24 2013-09-24
PCT/US2014/057295 WO2015048184A1 (en) 2013-09-24 2014-09-24 System for gas treatment of a cell implant

Publications (1)

Publication Number Publication Date
SG11201602232UA true SG11201602232UA (en) 2016-04-28

Family

ID=52744433

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201602232UA SG11201602232UA (en) 2013-09-24 2014-09-24 System for gas treatment of a cell implant

Country Status (13)

Country Link
US (3) US10231817B2 (en)
EP (1) EP3049020B1 (en)
JP (1) JP6749239B2 (en)
KR (1) KR102323291B1 (en)
CN (2) CN110101485B (en)
AU (1) AU2014326794B2 (en)
BR (1) BR112016006378A2 (en)
CA (2) CA3059017C (en)
IL (1) IL244714B (en)
MX (1) MX2016003615A (en)
SA (1) SA516370789B1 (en)
SG (1) SG11201602232UA (en)
WO (1) WO2015048184A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10091985B2 (en) 2009-06-18 2018-10-09 Giner, Inc. Perfusing an organ with an in situ generated gas
MX2012002440A (en) 2009-08-28 2012-06-19 Sernova Corp Methods and devices for cellular transplantation.
MX2017012982A (en) 2015-04-10 2018-07-06 Univ Jefferson Methods and compositions for treating cancers and enhancing therapeutic immunity by selectively reducing immunomodulatory m2 monocytes.
WO2017175065A2 (en) * 2016-04-04 2017-10-12 Beta-O2 Technologies Ltd. Implantable device for implantation of cells having anti-inflammatory and vascularization capabilities and methods of making thereof
WO2018067813A1 (en) 2016-10-05 2018-04-12 The Arizona Board Of Regents On Behalf Of The University Of Arizona Methods and systems for augmenting immune system responses
AU2017396753B2 (en) 2016-11-03 2021-04-29 Arizona Board Of Regents On Behalf Of The University Of Arizona Stacked tissue encapsulation device systems with or without oxygen delivery
KR20190106996A (en) * 2016-11-03 2019-09-18 아리조나 보드 오브 리전츠 온 비해프 오브 더 유니버시티 오브 아리조나 Encapsulation system with oxygen sensor with or without external oxygen transfer
WO2018144099A1 (en) * 2016-11-03 2018-08-09 The Arizona Board Of Regents On Behalf Of The University Of Arizona Methods and systems for real-time assessment of cells in encapsulation devices pre-and post-transplantation
AU2017366791B2 (en) * 2016-11-03 2021-01-21 Arizona Board Of Regents On Behalf Of The University Of Arizona Methods, systems, and implantable devices for enhancing blood glucose regulation
USD824042S1 (en) * 2016-11-10 2018-07-24 Viacyte, Inc. Perforated cell encapsulation device
AU2017361260B2 (en) * 2016-11-15 2023-06-08 Giner, Inc. Percutaneous gas diffusion device suitable for use with a subcutaneous implant
WO2018093940A1 (en) * 2016-11-15 2018-05-24 Giner, Inc. Self-regulating electrolytic gas generator and implant system comprising the same
CN110832068A (en) 2017-03-09 2020-02-21 托马斯杰弗逊大学 Methods and compositions for treating cancer using antisense molecules
EP3398558A1 (en) * 2017-05-02 2018-11-07 Carlo Andretta In body perfusion system
WO2018204867A1 (en) * 2017-05-04 2018-11-08 Giner, Inc. Robust, implantable gas delivery device and methods, systems and devices including same
IL308120B1 (en) 2017-06-14 2024-08-01 Vertex Pharma Devices and methods for delivering therapeutics
EP3687499A4 (en) * 2017-09-29 2021-06-30 Semma Therapeutics, Inc. Cell housing device
JP2019097442A (en) * 2017-11-30 2019-06-24 株式会社日立製作所 Immunoisolation device
FR3075831B1 (en) * 2017-12-22 2020-11-13 Univ Grenoble Alpes IMPLANTABLE HYDROGEN PRODUCTION DEVICE
CA3089583A1 (en) * 2018-01-24 2019-08-01 Thomas Jefferson University Biodiffusion chamber
EP3810250A4 (en) * 2018-05-14 2022-07-13 Giner Life Sciences, Inc. System and method for controlling oxygen delivery to implanted cells
WO2019222704A1 (en) 2018-05-17 2019-11-21 Giner Life Sciences, Inc. Electrolytic gas generator with combined lead and gas port terminals
US11963862B2 (en) * 2018-08-22 2024-04-23 Boston Scientific Scimed, Inc. Cell encapsulation device including a porous tube
US20210401564A1 (en) * 2018-09-24 2021-12-30 Arizona Board Regents On Behalf Of The University Of Arizona Methods and systems for implantable medical devices and vascularization membranes
WO2020206157A1 (en) * 2019-04-03 2020-10-08 Vertex Pharmaceuticals Incorporated Multicompartment macroencapsulation devices
WO2021202975A1 (en) * 2020-04-03 2021-10-07 The Brigham And Women's Hospital, Inc. Implantable cell macroencapsulation device and method of manufacture and use
CA3196876A1 (en) 2020-10-30 2022-05-05 Klearchos Papas Methods and systems for encapsulation devices for housing cells and agents
US20220152369A1 (en) * 2020-11-18 2022-05-19 Giner Life Sciences, Inc. Wearable system and method for gas delivery to exterior surface of an eye
WO2023282968A1 (en) * 2021-07-06 2023-01-12 Massachusetts Institute Of Technology Bioelectronic devices to support transplanted cells in vivo for encapsulated cell therapies
WO2023107698A1 (en) * 2021-12-09 2023-06-15 Encellin, Inc. Methods and devices for pre-vascularization of implantation sites and/or cell encapsulation devices
WO2023205302A2 (en) * 2022-04-20 2023-10-26 Northwestern University Oxygen generation system and applications thereof

Family Cites Families (129)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US150995A (en) 1874-05-19 Improvement ifs
US3005943A (en) 1957-04-10 1961-10-24 Electric Storage Battery Co Sealed storage cell using liquid electrolyte
US3453086A (en) 1965-10-12 1969-07-01 Gen Electric Self-regulating gas generator
US3373057A (en) 1965-10-24 1968-03-12 Texas Instruments Inc Battery having an automatic circuit breaker therein
US3783868A (en) 1971-05-06 1974-01-08 Gulf Oil Corp Percutaneous implant
US3933526A (en) 1974-09-09 1976-01-20 Motorola, Inc. Housing for battery cell with protection for pressure and temperature
US4057479A (en) 1976-02-26 1977-11-08 Billings Energy Research Corporation Solid polymer electrolyte cell construction
US4385093A (en) 1980-11-06 1983-05-24 W. L. Gore & Associates, Inc. Multi-component, highly porous, high strength PTFE article and method for manufacturing same
US4648391A (en) 1985-11-18 1987-03-10 Carbomedics, Inc. Stabilizer for percutaneous medical devices
ATE65159T1 (en) 1986-10-23 1991-08-15 Ciba Geigy Ag FIGHTING ECTOPARASITES.
DE3853278T2 (en) 1988-02-29 1995-07-13 Du Pont Device for delivering substances in cells and tissues in a non-lethal manner.
US4925732A (en) 1988-07-27 1990-05-15 W. L. Gore & Associates, Inc. Breathable flexible laminates adhered by a breathable adhesive
US5011472A (en) 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
US5344454A (en) 1991-07-24 1994-09-06 Baxter International Inc. Closed porous chambers for implanting tissue in a host
CA2070816A1 (en) 1990-10-31 1992-05-01 James H. Brauker Close vascularization implant material
US5713888A (en) 1990-10-31 1998-02-03 Baxter International, Inc. Tissue implant systems
US6773458B1 (en) 1991-07-24 2004-08-10 Baxter International Inc. Angiogenic tissue implant systems and methods
US5264276A (en) 1992-04-06 1993-11-23 W. L. Gore & Associates, Inc. Chemically protective laminate
DE4227066A1 (en) 1992-08-16 1994-02-17 Bernhard Josef Dr Med Hering Langerhans Islands in pure form
US5338662A (en) 1992-09-21 1994-08-16 Bio-Preserve Medical Corporation Organ perfusion device
US5362622A (en) 1993-03-11 1994-11-08 Board Of Regents, The University Of Texas System Combined perfusion and oxygenation apparatus
US5356771A (en) 1993-03-11 1994-10-18 Board Of Regents, The University Of Texas System Combined perfusion and oxygenation organ preservation apparatus
DE4342728A1 (en) 1993-12-15 1995-06-22 Thomae Gmbh Dr K Aq. isotonic soln. for perfusion and preservation of explanted liver
US5586438A (en) 1995-03-27 1996-12-24 Organ, Inc. Portable device for preserving organs by static storage or perfusion
US5788682A (en) 1995-04-28 1998-08-04 Maget; Henri J.R. Apparatus and method for controlling oxygen concentration in the vicinity of a wound
US6060640A (en) 1995-05-19 2000-05-09 Baxter International Inc. Multiple-layer, formed-in-place immunoisolation membrane structures for implantation of cells in host tissue
WO1997010807A1 (en) 1995-09-22 1997-03-27 Gore Hybrid Technologies, Inc. Improved cell encapsulation device
GB9606452D0 (en) 1996-03-27 1996-06-05 Sandoz Ltd Organic compounds
WO1997042953A1 (en) 1996-05-10 1997-11-20 Novartis Ag Use of brequinar and derivatives in chronic rejection of allografts and xenotransplantation
US5965433A (en) 1996-05-29 1999-10-12 Trans D.A.T.A. Service, Inc. Portable perfusion/oxygenation module having mechanically linked dual pumps and mechanically actuated flow control for pulsatile cycling of oxygenated perfusate
EP1208847B8 (en) 1996-07-30 2007-02-14 Novartis AG Pharmaceutical compositions for the treatment of transplant rejection, as well as autoimmune or inflammatory conditions
US5951538A (en) 1997-08-07 1999-09-14 Ceramatec, Inc. Gas generating device for delivering beneficial agents to a body cavity
US6368592B1 (en) 1998-07-17 2002-04-09 Massachusetts Institute Of Technology Method of delivering oxygen to cells by electrolyzing water
US6673594B1 (en) 1998-09-29 2004-01-06 Organ Recovery Systems Apparatus and method for maintaining and/or restoring viability of organs
US6977140B1 (en) 1998-09-29 2005-12-20 Organ Recovery Systems, Inc. Method for maintaining and/or restoring viability of organs
US6171368B1 (en) 1998-11-06 2001-01-09 Med-E-Cell Gas extraction from closed containers
US20040213768A1 (en) 1999-04-30 2004-10-28 Elliott Robert Bartlett Preparation for biotransplantation and xenotransplantion and uses thereof
ATE474590T1 (en) 1999-05-10 2010-08-15 Paolo Brenner COMBINATION OF IMMUNOSUPRESSIVE SUBSTANCES FOR THE TREATMENT OR PREVENTION OF TRANSPLANT REJECTION
US6413238B1 (en) 1999-09-17 2002-07-02 Baxter International Inc Fluid dispenser with stabilized fluid flow
US8012500B2 (en) 2000-01-01 2011-09-06 Beta-O2 Technologies Ltd. Implantable device
IL134009A (en) 2000-01-12 2011-07-31 Bo2 Technologies Ltd Implantable device
US6268592B1 (en) * 2000-01-18 2001-07-31 Tsann Kuen Usa, Inc. Electric grill plate appliance for tortilla cuisine
US6492103B1 (en) 2000-01-31 2002-12-10 Organ Recovery Systems, Inc. System for organ and tissue preservation and hypothermic blood substitution
EP1146117B1 (en) 2000-04-12 2008-01-23 Beta-Cell N.V. A method for producing preparations of mature and immature pancreatic endocrine cells, the cell preparation and its use for treatment of diabetes mellitus
WO2001093908A1 (en) 2000-06-02 2001-12-13 Regents Of The University Of Minnesota Immunotherapeutic method to prevent islet cell rejection
US6824915B1 (en) 2000-06-12 2004-11-30 The Gillette Company Air managing systems and methods for gas depolarized power supplies utilizing a diaphragm
USD453828S1 (en) 2000-08-25 2002-02-19 Organ Recovery Systems, Inc. Organ perfusion apparatus
DE10045683C2 (en) 2000-09-15 2002-09-05 Draegerwerk Ag Electrochemical oxygen concentrator
US6475716B1 (en) 2001-03-06 2002-11-05 Biobank Co., Ltd. Method for preserving mammalian organs
US20030008192A1 (en) 2001-04-10 2003-01-09 Freund Michael S. Actuatable and reversible pressure generation based on fuel cell operation
US20030031652A1 (en) 2001-04-16 2003-02-13 Bernhard Hering Systems and methods for inducing mixed chimerism
US6677150B2 (en) 2001-09-14 2004-01-13 Organ Transport Systems, Inc. Organ preservation apparatus and methods
US7073005B1 (en) 2002-01-17 2006-07-04 Juniper Networks, Inc. Multiple concurrent dequeue arbiters
US20030207161A1 (en) 2002-05-01 2003-11-06 Ali Rusta-Sallehy Hydrogen production and water recovery system for a fuel cell
US7572622B2 (en) 2002-08-14 2009-08-11 Transmedic, Inc. Heart preservation chamber
US8721515B2 (en) 2003-01-31 2014-05-13 L-Vad Technology, Inc. Rigid body aortic blood pump implant
CN1438313A (en) * 2003-03-08 2003-08-27 浙江大学医学院附属第二医院 Method for preparing microcapsulized functional cell
US7504201B2 (en) 2004-04-05 2009-03-17 Organ Recovery Systems Method for perfusing an organ and for isolating cells from the organ
BRPI0510550A (en) 2004-05-03 2007-11-20 Ams Res Corp surgical implant, surgical kit, method for forming or assembling a surgical implant, insertion mold, apparatus, and method for producing a surgical implant
US8034102B2 (en) * 2004-07-19 2011-10-11 Coroneo, Inc. Aortic annuloplasty ring
US8298813B2 (en) 2004-09-23 2012-10-30 Dennis Holman Method for preparing an expanded product for fermentation
IL311989A (en) 2004-10-07 2024-06-01 Transmedics Inc Systems and methods for ex-vivo organ care
EP1809101B1 (en) 2004-11-12 2016-11-02 Organoflush B.V. Composition for cold preservation and perfusion of organs
US20060182722A1 (en) 2005-02-11 2006-08-17 Hering Bernhard J Methods and materials for isolating isogenic islet cells
NZ539491A (en) 2005-04-15 2008-04-30 Living Cell Products Pty Ltd Swine population and uses thereof
NL1028848C2 (en) 2005-04-22 2006-10-24 Doorzand Airdrive B V Device for transporting an organ.
WO2006122169A2 (en) * 2005-05-10 2006-11-16 Ogenix Corporation Novel portable electrochemical devices for dual action wound healing
US9078428B2 (en) 2005-06-28 2015-07-14 Transmedics, Inc. Systems, methods, compositions and solutions for perfusing an organ
US20090209031A1 (en) 2006-01-26 2009-08-20 Tyco Healthcare Group Lp Medical device package
CA2646674A1 (en) 2006-04-20 2007-11-01 Fred Hutchinson Cancer Research Center Use of chalcogenides for treating shock and other adverse conditions
TW200806392A (en) 2006-06-20 2008-02-01 Lynntech Inc Microcartridge hydrogen generator
US20100028398A1 (en) 2006-11-21 2010-02-04 Living Cell Technologies Limited Cell implantation to prevent and/or treat hearing loss
AU2007200990B8 (en) 2006-11-21 2011-05-12 Living Cell Technologies Limited Cell Implantation To Prevent and/or Treat Hearing Loss
ES2659988T3 (en) * 2006-11-28 2018-03-20 Beta O2 Technologies Ltd. Oxygen supply for cell transplantation and vascularization
WO2008079997A2 (en) * 2006-12-22 2008-07-03 Medtronic, Inc. Implantable device, angiogenesis mechanism and methods
MX2009008294A (en) 2007-02-02 2010-03-18 Univ Miami Therapeutic hybrid implantable devices.
US20080245672A1 (en) 2007-04-03 2008-10-09 New Sky Energy, Inc. Electrochemical methods to generate hydrogen and sequester carbon dioxide
US8083821B2 (en) 2007-04-13 2011-12-27 Giner, Inc. System for modifying the atmosphere within an enclosed space and incubator system including the same
WO2009023409A1 (en) 2007-07-24 2009-02-19 Rovcal, Inc. On-demand hydrogen gas generation device with pressure-regulating switch
US8821431B2 (en) * 2007-09-07 2014-09-02 Beta O2 Technologies Ltd. Air gap for supporting cells
US8110283B2 (en) 2007-09-28 2012-02-07 General Electric Company Article and associated method
US8287506B2 (en) 2007-10-26 2012-10-16 Electrochemical Oxygen Concepts, Inc. Apparatus and methods for controlling tissue oxygenation for wound healing and promoting tissue viability
US10750738B2 (en) 2008-01-31 2020-08-25 Transmedics, Inc. Systems and methods for ex vivo lung care
US8338170B2 (en) 2008-04-21 2012-12-25 Viacyte, Inc. Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells
DE102008045621A1 (en) 2008-09-03 2010-03-04 Novalung Gmbh Gas transfer device and use of a structured membrane
WO2010049996A1 (en) 2008-10-28 2010-05-06 株式会社レゾナンスクラブ Method of preserving mammalian organ
US20100108534A1 (en) 2008-10-30 2010-05-06 Mti Micro Fuel Cells, Inc. Electrochemical actuator
EP4176888A1 (en) 2008-11-14 2023-05-10 ViaCyte, Inc. Encapsulation of pancreatic cells derived from human pluripotent stem cells
US8043271B2 (en) 2008-11-26 2011-10-25 Beta 02 Technologies Ltd. Apparatus for transportation of oxygen to implanted cells
WO2010091074A2 (en) 2009-02-03 2010-08-12 Purdue Research Foundation Method and apparatus for improving local hypoxicity for enhanced therapy
US20100209475A1 (en) * 2009-02-19 2010-08-19 Biomet Manufacturing Corp. Medical implants having a drug delivery coating
US10091985B2 (en) 2009-06-18 2018-10-09 Giner, Inc. Perfusing an organ with an in situ generated gas
US9357764B2 (en) 2009-06-18 2016-06-07 Giner, Inc. System for fluid perfusion of biological matter comprising tissue
IN2012DN00526A (en) 2009-08-07 2015-08-28 Zeus Ind Products Inc
US8784389B2 (en) * 2009-08-31 2014-07-22 Beta-O2 Technologies Ltd. Oxygen supply for implantable medical device
WO2011038251A1 (en) 2009-09-25 2011-03-31 Board Of Regents, The University Of Texas System Fluidics based pulsatile perfusion preservation device and method
GB201002370D0 (en) 2010-02-12 2010-03-31 Renishaw Ireland Ltd Percutaneous drug delivery apparatus
KR101813300B1 (en) 2010-04-08 2017-12-28 힐리오닉스 코포레이션 Implantable medical devices having microporous surface layers and method for reducing foreign body response to the same
EP2571543B1 (en) 2010-05-11 2018-12-05 Allergan, Inc. Porous materials, methods of making and uses
JP5502615B2 (en) 2010-06-23 2014-05-28 本田技研工業株式会社 Fuel cell
WO2012115619A1 (en) 2011-02-21 2012-08-30 Viacyte, Inc. Loading system for an encapsulation device
WO2012130567A1 (en) 2011-03-29 2012-10-04 Beta-Cell Nv Method for encapsulated therapeutic products and uses thereof
DE102012112709B4 (en) * 2011-12-30 2022-09-08 Giner Life Sciences, Inc. System for fluid perfusion or persufflation of biological material comprising tissue
WO2014138691A1 (en) 2013-03-07 2014-09-12 Viacyte, Inc. 3-dimensional large capacity cell encapsulation device assembly
WO2014171842A1 (en) 2013-04-19 2014-10-23 Living Cell Technologies New Zealand Limited Biocompatible encapsulation system
CN105555950B (en) 2013-06-13 2021-03-05 奥尔吉尼西丝有限公司 Cell populations, methods of transdifferentiation and methods of use thereof
US20160228377A1 (en) 2013-09-19 2016-08-11 Beta-Cell Nv Method for the treatment of diabetes mellitus
EP3066468B1 (en) 2013-11-07 2023-03-29 Vrije Universiteit Brussel Screening assay for agents that influence beta cell number and/or phenotype
CN116059378A (en) 2014-12-10 2023-05-05 明尼苏达大学董事会 Genetically modified cells, tissues and organs for the treatment of diseases
MA41296A (en) 2014-12-30 2017-11-07 Orgenesis Ltd TRANSDIFFERENTIATION PROCESSES AND METHODS FOR USING THE SAME
RU2017143158A (en) 2015-05-15 2019-06-17 Ливин Селл Текнолоджис Нью Зиланд Лимитед TREATMENT OF CNS DISEASES WITH THE HELP OF INCAPSULATED INDUCED VASCULAR WEAVING CELLS
WO2017160850A1 (en) 2016-03-14 2017-09-21 The Regents Of The University Of California Nanostraw devices and methods of fabricating and using the same
WO2017175065A2 (en) 2016-04-04 2017-10-12 Beta-O2 Technologies Ltd. Implantable device for implantation of cells having anti-inflammatory and vascularization capabilities and methods of making thereof
US20190119462A1 (en) 2016-06-14 2019-04-25 The Regents Of The University Of California Porous Polymer Scaffolds, and Methods of Making and Using the Same
KR20190017985A (en) 2016-06-14 2019-02-20 리전츠 오브 더 유니버스티 오브 미네소타 Genetically modified cells, tissues, and organs for treating diseases
WO2018144099A1 (en) 2016-11-03 2018-08-09 The Arizona Board Of Regents On Behalf Of The University Of Arizona Methods and systems for real-time assessment of cells in encapsulation devices pre-and post-transplantation
KR20190106996A (en) 2016-11-03 2019-09-18 아리조나 보드 오브 리전츠 온 비해프 오브 더 유니버시티 오브 아리조나 Encapsulation system with oxygen sensor with or without external oxygen transfer
AU2017396753B2 (en) 2016-11-03 2021-04-29 Arizona Board Of Regents On Behalf Of The University Of Arizona Stacked tissue encapsulation device systems with or without oxygen delivery
AU2017366791B2 (en) 2016-11-03 2021-01-21 Arizona Board Of Regents On Behalf Of The University Of Arizona Methods, systems, and implantable devices for enhancing blood glucose regulation
WO2018093940A1 (en) 2016-11-15 2018-05-24 Giner, Inc. Self-regulating electrolytic gas generator and implant system comprising the same
AU2017361260B2 (en) 2016-11-15 2023-06-08 Giner, Inc. Percutaneous gas diffusion device suitable for use with a subcutaneous implant
WO2018204867A1 (en) 2017-05-04 2018-11-08 Giner, Inc. Robust, implantable gas delivery device and methods, systems and devices including same
WO2018207179A1 (en) 2017-05-08 2018-11-15 Orgenesis Ltd. Transdifferentiated cell populations and methods of use thereof
WO2018220623A1 (en) 2017-05-29 2018-12-06 Orgenesis Ltd. Compositions and methods for providing cell replacement therapy
US20200263196A1 (en) 2017-09-27 2020-08-20 Sigilon Therapeutics, Inc. Methods, compositions, and implantable elements comprising active cells
WO2019089993A1 (en) 2017-11-02 2019-05-09 Living Cell Technologies New Zealand Limited Pericyte protective agents for neurological disorders including neurodegenerative diseases, central nervous system diseases and others
WO2019089943A1 (en) 2017-11-06 2019-05-09 Theranova, Llc Methods and devices for delivering pancreatic islet function to a body
US11793622B2 (en) 2018-05-08 2023-10-24 Michael J. Dalton Artificial interstitium device
WO2019241562A1 (en) 2018-06-14 2019-12-19 University Of Miami Methods of implanting cells

Also Published As

Publication number Publication date
US10231817B2 (en) 2019-03-19
JP2016530980A (en) 2016-10-06
BR112016006378A2 (en) 2017-08-01
CA3059017C (en) 2021-05-25
JP6749239B2 (en) 2020-09-02
CN110101485B (en) 2021-07-06
CN110101485A (en) 2019-08-09
US20190336267A1 (en) 2019-11-07
SA516370789B1 (en) 2020-03-04
WO2015048184A1 (en) 2015-04-02
EP3049020B1 (en) 2022-06-15
EP3049020A1 (en) 2016-08-03
CA2924681A1 (en) 2015-04-02
IL244714A0 (en) 2016-04-21
US12070383B2 (en) 2024-08-27
AU2014326794A1 (en) 2016-04-21
EP3049020A4 (en) 2017-07-26
KR102323291B1 (en) 2021-11-05
CA3059017A1 (en) 2015-04-02
AU2014326794B2 (en) 2019-03-21
US20240189088A1 (en) 2024-06-13
KR20160060115A (en) 2016-05-27
IL244714B (en) 2020-06-30
CN105792775B (en) 2019-02-19
CN105792775A (en) 2016-07-20
CA2924681C (en) 2019-12-31
US11701215B2 (en) 2023-07-18
US20150112247A1 (en) 2015-04-23
MX2016003615A (en) 2016-10-26

Similar Documents

Publication Publication Date Title
IL244714B (en) System for gas treatment of a cell implant
IL266651B (en) Implant
ZA201507790B (en) Enhanced adoptive cell therapy
IL241627B (en) Method for activating t cells
EP2997133C0 (en) Methods for engineering highly active t cell for immunotherapy
PL2959959T3 (en) Exhaust gas treatment system
EP2978387A4 (en) Dental implant positioning system
HK1202271A1 (en) An implant
SG11201505771VA (en) Nasal implant
PL2764881T3 (en) System for medical treatment
SG11201602581WA (en) Gas treatment apparatus
EP2820125A4 (en) Expansion of alloantigen-reactive regulatory t cells
PL2879622T3 (en) Control for orthotic devices
EP2883595A4 (en) Exhaust gas treatment system
GB201304417D0 (en) Compounds for targetting cancer stem cells
GB2525562B (en) Methods for purification of biological cells
ZA201507475B (en) Method for the treatment of gas
GB201205993D0 (en) Control of prosthetic devices
TWM476907U (en) Gas treatment apparatus
GB2513353B (en) Process of gas containment
ZA201601626B (en) Treatment of gases
PL3041506T3 (en) A method of treatment
RS61353B1 (en) Facility and procedure for treatment of a solidificate
EP2886078B1 (en) Dental implant system
IL230230A0 (en) Implant